Literature DB >> 23660814

Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide.

Chidambar Balbhim Jalkute1, Sagar Hindurao Barage, Maruti Jayram Dhanavade, Kailas Dasharath Sonawane.   

Abstract

Angiotensin converting enzyme (ACE) cleaves amyloid beta peptide. So far this cleavage mechanism has not been studied in detail at atomic level. Keeping this view in mind, we performed molecular dynamics simulation of crystal structure complex of testis truncated version of ACE (tACE) and its inhibitor lisinopril along with Zn(2+) to understand the dynamic behavior of active site residues of tACE. Root mean square deviation results revealed the stability of tACE throughout simulation. The residues Ala 354, Glu 376, Asp 377, Glu 384, His 513, Tyr 520 and Tyr 523 of tACE stabilized lisinopril by hydrogen bonding interactions. Using this information in subsequent part of study, molecular docking of tACE crystal structure with Aβ-peptide has been made to investigate the interactions of Aβ-peptide with enzyme tACE. The residues Asp 7 and Ser 8 of Aβ-peptide were found in close contact with Glu 384 of tACE along with Zn(2+). This study has demonstrated that the residue Glu 384 of tACE might play key role in the degradation of Aβ-peptide by cleaving peptide bond between Asp 7 and Ser 8 residues. Molecular basis generated by this attempt could provide valuable information towards designing of new therapies to control Aβ concentration in Alzheimer's patient.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23660814     DOI: 10.1007/s10930-013-9492-3

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  42 in total

1.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

2.  Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease.

Authors:  N M Barnes; C H Cheng; B Costall; R J Naylor; T J Williams; C M Wischik
Journal:  Eur J Pharmacol       Date:  1991-08-06       Impact factor: 4.432

3.  The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide.

Authors:  Ryutaro Oba; Akira Igarashi; Makiko Kamata; Kinya Nagata; Syoichi Takano; Hachiro Nakagawa
Journal:  Eur J Neurosci       Date:  2005-02       Impact factor: 3.386

4.  Probing the outer mouth structure of the HERG channel with peptide toxin footprinting and molecular modeling.

Authors:  Gea-Ny Tseng; Kailas D Sonawane; Yuliya V Korolkova; Mei Zhang; Jie Liu; Eugene V Grishin; H Robert Guy
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

5.  Molecular dynamics simulations of Zn(2+) coordination in protein binding sites.

Authors:  Richard Tjörnhammar; Olle Edholm
Journal:  J Chem Phys       Date:  2010-05-28       Impact factor: 3.488

6.  Identification of two active site residues in human angiotensin I-converting enzyme.

Authors:  T A Williams; P Corvol; F Soubrier
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

Review 7.  Deciphering the molecular basis of memory failure in Alzheimer's disease.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

8.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

9.  Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease.

Authors:  H Sticht; P Bayer; D Willbold; S Dames; C Hilbich; K Beyreuther; R W Frank; P Rösch
Journal:  Eur J Biochem       Date:  1995-10-01

10.  Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.

Authors:  Kun Zou; Haruyasu Yamaguchi; Hiroyasu Akatsu; Takaaki Sakamoto; Mihee Ko; Kazushige Mizoguchi; Jian-Sheng Gong; Wenxin Yu; Takayuki Yamamoto; Kenji Kosaka; Katsuhiko Yanagisawa; Makoto Michikawa
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

View more
  11 in total

1.  Structural Characterizations of the Fas Receptor and the Fas-Associated Protein with Death Domain Interactions.

Authors:  Urmi Roy
Journal:  Protein J       Date:  2016-02       Impact factor: 2.371

2.  Homology modeling, molecular docking and DNA binding studies of nucleotide excision repair UvrC protein from M. tuberculosis.

Authors:  Rishikesh S Parulekar; Sagar H Barage; Chidambar B Jalkute; Maruti J Dhanavade; Prayagraj M Fandilolu; Kailas D Sonawane
Journal:  Protein J       Date:  2013-08       Impact factor: 2.371

3.  Conformational transition pathway in the inhibitor binding process of human monoacylglycerol lipase.

Authors:  Huayou Chen; Rui Tian; Zhong Ni; Zhongge Zhang; Hongzhang Chen; Qi Guo; Milton H Saier; Ake Vastermark
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

4.  Virtual screening following rational drug design based approach for introducing new anti amyloid beta aggregation agent.

Authors:  Garshasb Rigi; Mohammad Vala Ashdar Nakhaei; Hoda Eidipour; Arshia Najimi; Fahimeh Tajik; Niloufar Taher; Kamran Yarahmadi
Journal:  Bioinformation       Date:  2017-02-28

5.  Heptapeptide Isolated from Isochrysis zhanjiangensis Exhibited Anti-Photoaging Potential via MAPK/AP-1/MMP Pathway and Anti-Apoptosis in UVB-Irradiated HaCaT Cells.

Authors:  Zhaowan Zheng; Zhenbang Xiao; Yuan-Lin He; Yanfei Tang; Lefan Li; Chunxia Zhou; Pengzhi Hong; Hui Luo; Zhong-Ji Qian
Journal:  Mar Drugs       Date:  2021-11-09       Impact factor: 5.118

6.  Gaussian Accelerated Molecular Dynamics Simulations Investigation on the Mechanism of Angiotensin-Converting Enzyme (ACE) C-Domain Inhibition by Dipeptides.

Authors:  Congcong Li; Kaifeng Liu; Siao Chen; Lu Han; Weiwei Han
Journal:  Foods       Date:  2022-01-25

7.  Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-Coronavirus-2: A molecular modeling approach.

Authors:  Kailas D Sonawane; Sagar S Barale; Maruti J Dhanavade; Shailesh R Waghmare; Naiem H Nadaf; Subodh A Kamble; Ali Abdulmawjood Mohammed; Asiya M Makandar; Prayagraj M Fandilolu; Ambika S Dound; Nitin M Naik; Vikramsinh B More
Journal:  Inform Med Unlocked       Date:  2021-05-26

8.  AutoDock4(Zn): an improved AutoDock force field for small-molecule docking to zinc metalloproteins.

Authors:  Diogo Santos-Martins; Stefano Forli; Maria João Ramos; Arthur J Olson
Journal:  J Chem Inf Model       Date:  2014-07-18       Impact factor: 4.956

9.  Spontaneous Hinge-Bending Motions of Angiotensin I Converting Enzyme: Role in Activation and Inhibition.

Authors:  Thi Tuong Vy; Seong-Yeong Heo; Won-Kyo Jung; Myunggi Yi
Journal:  Molecules       Date:  2020-03-12       Impact factor: 4.411

10.  A Novel Angiotensin-I-Converting Enzyme (ACE) Inhibitory Peptide from Takifugu flavidus.

Authors:  Yongchang Su; Shicheng Chen; Shuilin Cai; Shuji Liu; Nan Pan; Jie Su; Kun Qiao; Min Xu; Bei Chen; Suping Yang; Zhiyu Liu
Journal:  Mar Drugs       Date:  2021-11-23       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.